Arbutus Biopharma Corporation (ABUS): Price and Financial Metrics
ABUS Price/Volume Stats
| Current price | $3.48 | 52-week high | $4.72 |
| Prev. close | $3.40 | 52-week low | $2.70 |
| Day low | $3.44 | Volume | 557,500 |
| Day high | $3.54 | Avg. volume | 915,647 |
| 50-day MA | $3.30 | Dividend yield | N/A |
| 200-day MA | $3.54 | Market Cap | 666.51M |
ABUS Stock Price Chart Interactive Chart >
Arbutus Biopharma Corporation (ABUS) Company Bio
Arbutus Biopharma Corporation, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of chronic hepatitis B (HBV) infections in Canada and the United States. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. The company is based in Burnaby, Canada.
ABUS Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ABUS Price Returns
| 1-mo | 5.45% |
| 3-mo | 5.14% |
| 6-mo | -5.43% |
| 1-year | 8.75% |
| 3-year | 29.85% |
| 5-year | 70.17% |
| YTD | 6.42% |
| 2024 | 30.80% |
| 2023 | 7.30% |
| 2022 | -40.10% |
| 2021 | 9.58% |
| 2020 | 27.70% |